Erigeron breviscapus injectio in the treatment of coronary heart disease with angina pectoris in 31 patients

In 46 patients suffered from coronary disease with angina pectoris, 31 patients (M18, F13; age 60±11yr) received Erigeron breviscapus 80mg in 10% glucose 500mL iv gtt qd×14, the clinical efficacy was 87% and the ECG efficacy was 11%. While the other 15 patients received Fufang Danshen injection 16mL(2mL/Amp, each Amp consist of Salvia miltiorrhiza Ig and Dalbergia odorifera Ig) in 10% glucose 500mL iv gtt qd×14 as control, the clinical efficacy was 80%, and the ECG efficacy was 40%, the ECG efficacy of Erigeron breviscapus was higher than that of Fufang Danshen, but no statistical significance (P0.05).